INGSA2024 Full Conference Programme
The Full Conference Programme for INGSA2024 – The Transformation Imperative: Expanded Evidence for Inclusive Policies in Diverse Contexts. To watch the sessions and access the Resources see the conference website.
The Full Conference Programme for INGSA2024 – The Transformation Imperative: Expanded Evidence for Inclusive Policies in Diverse Contexts. To watch the sessions and access the Resources see the conference website.
Outcome Document and Summary of 2nd meeting of the G20 CSA Roundtable as part of India’s G20 Presidency 2023. Held: Gandhinagar, Gujarat – 28 August 2023
Open Access Chapter from the 2023 Book: The Politics of Modelling: Numbers Between Science and Policy available at: https://academic.oup.com/book/46867 Paper Abstract There are reliable, empirically tested models for some phenomena. These are not the subject of this chapter. There are also many models with little or no scientific connection to what they purport to explain….
The INGSA Strategic Plan for 2022-2025.
The Constitution of INGSA as confirmed in March 2021 – the underpinnning processes and values that guide INGSA
The Conference Report from the 2nd International Conference on Science Advice to Governments – hosted by INGSA and the European Commission – 29th – 30th September 2016, Brussels, Belgium
The INGSA2018 Conference Information Pack – detailing Program and Speakers. For the INGSA2018 Conference Report see here: https://ingsa.org/resources/ingsa2018-report/
The Conference Report delivered post-INGSA2018 – summarising the sessions and the outcomes of the 3rd International Conference on Science Advice to Governments. To see the Information pack that was provided to delegates of INGSA2018, please see: https://ingsa.org/resources/ingsa2018-information-booklet/
This is a guide for policymakers on using REAs (Rapid Evidence Assessments) for policy and the upsides and downsides of their usage.
This article investigates Hong Kong’s health policy science advice mechanisms and how they evolved through SARS and Covid-19.
End of content
End of content